Drug Profile
Research programme: vascular endothelial growth factor - Genix
Alternative Names: VEGF - GenixLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator University of California at San Francisco
- Developer Genix Therapeutics
- Class Growth factors
- Mechanism of Action Vascular endothelial growth factor receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Erectile dysfunction
Most Recent Events
- 17 Jun 2013 Discontinued - Preclinical for Erectile dysfunction in USA (Parenteral)
- 13 Jul 2004 Preclinical trials in Erectile dysfunction in USA (Parenteral)